[Robot-assisted prostatectomy for PT3. Oncological and functional outcomes].
Urologiia
; (6): 133-137, 2023 Dec.
Article
em Ru
| MEDLINE
| ID: mdl-38156697
ABSTRACT
In 2020, prostate cancer (PCa) ranked third in the structure of the most significant oncological diseases. In the Russian Federation, in terms of the frequency of detection among men, prostate cancer is second only to tumors of the upper respiratory tract and lungs, accounting for 14.9%. Radical prostatectomy (RP) in various modifications is still the most common treatment for localized prostate cancer, despite the existence of alternatives such as active surveillance, hormonal and radiation therapy, cryoablation, and others. And the technological pinnacle of the surgical treatment of prostate cancer at the moment is robot-assisted prostatectomy, the widespread use of which was marked by the publication of J. Binder back in 2002. This technology combined the advantages of minimally invasive laparoscopic RP with improved surgeon ergonomics and technical ease of vesicourethral anastomosis reconstruction and has now become the preferred minimally invasive approach. This article will consider the use of a robot-assisted technique in the stage of T3 prostate cancer.
Palavras-chave
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Robótica
/
Laparoscopia
/
Procedimentos Cirúrgicos Robóticos
Limite:
Humans
/
Male
Idioma:
Ru
Revista:
Urologiia
Ano de publicação:
2023
Tipo de documento:
Article